https://techpapersworld.com/wp-content/uploads/2024/03/One-Million-Global-Healthcare-1280x720.jpg

Caristo Diagnostics, a global leader in cardiovascular disease diagnostics and risk prediction, has been selected a winner of the Digital Health Hub Foundation: Digital Health Awards. Caristo was named a “Rising Star” in the Provider Diagnostics Category of the prestigious awards, presented Oct. 21 at the global HLTH 2024 conference in Las Vegas. Caristo’s CaRi-Heart® cardiac risk prediction technology was the first innovation highlighted in the conference’s opening ceremony by Jonathan Weiner, Founder, Chairman & CEO of HLTH. Caristo’s CaRi-Heart Technology showcased at HLTH...

https://techpapersworld.com/wp-content/uploads/2024/08/Invenio-Imaging-Announces-First-1280x720.jpg

AIRS Medical, a global leader in AI-powered diagnostic imaging solutions, has partnered with HealthCare Konnect, a prominent Swiss healthcare distribution platform. This collaboration will accelerate access to SwiftMR, the award-winning1 MRI acceleration software from AIRS Medical, throughout Switzerland. Enhancing MRI efficiency and patient care SwiftMR harnesses advanced deep learning technology to reduce MRI scan times by up to 50%2 while generating sharper images. By enabling radiology centers to scan more patients within the same time frame, SwiftMR not only boosts operational...

https://techpapersworld.com/wp-content/uploads/2024/07/iQIYI-Launches-AI-Chatbots-for-1280x720.jpg

VVDN Technologies, a global provider of Software, Product Engineering, Electronics Manufacturing Services, and Solutions, announces the integration of Google’s advanced Gen AI models and solutions, including Gemini Pro, into its workforce and existing IP products. By leveraging Google Cloud’s advanced capabilities, VVDN has built new industry solutions utilizing the Gemini family of AI models, developed joint go-to-market programs, and integrated Gemini Code Assist into its internal tools. This includes the development of GenAI solutions for...

https://techpapersworld.com/wp-content/uploads/2024/02/Oracle-Helps-Customers-Drive-1280x720.jpg

Hexaware Technologies, an IT services and solutions company, announced it has earned the Guidewire PartnerConnect Program Cloud – EMEA specialization. Hexaware is a Guidewire PartnerConnect Consulting partner at the Advantage level. This recognition underscores Hexaware’s experience delivering cloud-based solutions using Guidewire’s technology across Europe, the Middle East, and Africa (EMEA). Hexaware has been working with Guidewire to deliver solutions that meet insurance companies’ needs. This specialization is expected to strengthen the relationship between the two companies and help...

https://techpapersworld.com/wp-content/uploads/2024/04/Cerillion-harnesses-GenAI-1280x720.jpg

Fujitsu today announced the global launch of its Fujitsu Kozuchi AI Agent, an AI service that can engage in high-level tasks both autonomously and in collaboration with humans. This service will be offered through Fujitsu Data Intelligence PaaS, Fujitsu’s all-in-one operation platform that is part of the Fujitsu Uvance business model which works to provide cross-industry solutions to societal issues. As of today, Fujitsu will offer the first AI agent, for use in business profitability discussions...

https://techpapersworld.com/wp-content/uploads/2024/03/AI-Agents-Global-Challenge-1280x720.jpg

 Upscale Conf will bring together industry leaders and powerhouses to discuss the impact of genAI in the creative and design sectors. The event, set to take place in Spain on November 19th and 20th, will ignite high-level discussions on the impact of genAI and its relationship with creative professionals, how martech and adtech leaders are paving the way, AI key learnings and much more. In last month’s McKinsey Global Survey on AI, 65% of respondents report that their organizations are regularly using gen...

https://techpapersworld.com/wp-content/uploads/2024/07/PureHealth-Achieves-AED-1.0-billion-1280x720.png

Ariceum Therapeutics (Ariceum), a private biotech company developing radiopharmaceutical products for the diagnosis and treatment of certain hard-to-treat cancers, today announces that it presented data on its proprietary radiolabelled peptide SS0110 (satoreotide), a first-in-class antagonist of the somatostatin receptor 2 (SSTR2), at this year’s European Association of Nuclear Medicine (EANM) Annual Conference, held in Hamburg, Germany from 19-23 October 2024. The Top-Rated Oral Presentation (TROP) entitled ‘225Ac-SSO110 induces long-lasting anti-tumour responses in contrast to 225Ac-DOTA-TATE and 161Tb-DOTA-TATE in the treatment of SSTR2-positive...

https://techpapersworld.com/wp-content/uploads/2023/12/AI-Powered-Wealth-Management-Solutions-1280x720.jpg

Hanwha Defense USA and BlueSpace.ai announced their collaboration to bring to market BlueSpace’s advanced autonomous software solutions integrated into current and future HDUSA offerings. BlueSpace.ai leverages next-gen 4D sensing to provide verifiable and explainable AI solutions to provide ADAS and full autonomy solutions for defense and commercial applications, including mining and fleet operations, where the operational environments are challenging and often GPS-denied Credit: HDUSA The two technology leaders will work together to bring enhanced capabilities to...

https://techpapersworld.com/wp-content/uploads/2024/07/The-New-Face-of-Fraud-40-of-Business--1280x720.png

Global technology brand HONOR today announced that its upcoming Magic7 Series will be powered by the revolutionary Snapdragon® 8 Elite Mobile Platform from Qualcomm Technologies, Inc. At Snapdragon Summit 2024, HONOR revealed its plans to develop an AI-first ecosystem. On stage, HONOR showcased groundbreaking AI features coming to the Magic7 Series, including the industry’s first on-device AI Agent for an open ecosystem, and the first real-time NPU graphics rendering for mobile gaming. The company also gave a sneak...

https://techpapersworld.com/wp-content/uploads/2024/07/XRP-Healthcare-Halts-New-1280x720.jpg

HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for “Allogeneic Human iPSC-derived cardiomyocytes (HiCM-188) administered via intramyocardial injection during coronary artery bypass graft surgery.” Heart failure (HF) is a significant public health issue, affecting at least 7 million patients in the US and approximately 65 million globally. Due to its increasing incidence and prevalence among the elderly, heart...